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Ductal budding in the developing prostate is a testosterone-dependent event that involves signaling between the urogenital
sinus epithelium (UGE) and urogenital sinus mesenchyme (UGM). We show here that ductal bud formation is associated
with focused expression of Sonic hedgehog (Shh) in the epithelium of nascent prostate buds and in the growing tips of
elongating prostate ducts. This pattern of localized Shh expression occurs in response to testosterone stimulation. The gene
for the Shh receptor, Ptc1, is expressed in the UGM, as are the members of the Gli gene family of transcriptional regulators
(Gli1, Gli2, and Gli3). Expression of Ptc1, Gli1, and Gli2 is localized primarily to mesenchyme surrounding prostate buds,
whereas Gli3 is expressed diffusely throughout the UGM. A strong dependence of Gli1 (and Ptc1) expression on Shh
signaling is demonstrated by induction of expression in both the intact urogenital sinus and the isolated UGM by exogenous
SHH peptide. A similar dependence of Gli2 and Gli3 expression on Shh is not observed. Nonetheless, the chemical inhibitor
of Shh signaling, cyclopamine, produced a graded inhibition of Gli gene expression (Gli1>Gli2>Gli3) in urogenital sinus
explants that was paralleled by a severe inhibition of ductal budding. © 2002 Elsevier Science (USA)
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The adult mouse prostate is an exocrine gland comprised
of three paired lobes, each of which consists of a highly
branched ductal network connected to the urethral lumen
by multiple main ducts (Cunha and Lung, 1979; Cunha et
al., 1987). The prostate develops from the urogenital sinus
(UGS) in a specific region designated as the prostatic anlage,
a tubular structure comprised of a multilayered epithelium
surrounded by a mesenchymal sheath. The outgrowth of
the urogenital sinus epithelium (UGE) into the surrounding
urogenital sinus mesenchyme (UGM) heralds the formation
of buds that, subsequently, elongate and branch to generate
the complex ductal architecture of the adult prostate.
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All rights reserved.Prostate ductal budding begins in late gestation (embryonic
day 17.5 in the mouse) in response to testosterone stimu-
lation. Testosterone is postulated to induce ductal morpho-
genesis by promoting mesenchymal–epithelial interactions
that produce focal areas of cell proliferation and growth
(Cunha et al., 1987).
We have shown previously that the gene Sonic hedgehog
(Shh) is expressed in the UGE and that antibody neutralization
of hedgehog activity in a renal subcapsular prostate transplant
model inhibits prostate growth and glandular morphogenesis
(Podlasek et al., 1999). Shh is the vertebrate homolog of the
Drosophila gene hedgehog (hh). Just as hh is essential for
segmental patterning and imaginal disc development in Dro-
sophila, Shh has been shown to play critical roles in the
patterning and development of diverse structures in the ver-
tebrate embryo (Ingham and McMahon, 2001). Both hh and
Shh encode secreted glycopeptides that bind to a membrane-
bound receptor Patched (Ptc) and activate an intracellular
signal transduction mechanism that leads to transcriptionalE-mail: bushman@surgery.wisc.edu.349
activation or repression of specific target genes (Johnson and
Scott, 1998; Ingham and McMahon, 2001).
The actions of hh and Shh on gene transcription have
been attributed to the function of transcriptional regulators
that are modulated by hedgehog signaling. In Drosophila,
Ci is the transcriptional regulator and it functions both as
an activator (full-length protein) and repressor (N-terminal
processed form) of hh target genes (Ruiz i Altaba, 1997;
Aza-Blanc and Kornberg, 1999). The functions of Ci in
vertebrates are assumed by three Gli proteins, which share
a highly conserved zinc finger DNA-binding domain with
Ci: Gli1, Gli2, and Gli3 (Walterhouse et al., 1999; Matise
and Joyner, 1999; Ingham and McMahon, 2001). Although
Gli1 is clearly a transcriptional activator (Sasaki et al.,
1997; Yoon et al., 1998) and functions as a mediator of Shh
signaling (Hynes et al., 1997; Lee et al., 1997; Platt et al.,
1997; Sasaki et al., 1997; Ruiz i Altaba, 1998; Aza-Blanc et
al., 2000), observations in several developmental systems
suggest an overlap in the transcriptional activating func-
tions of Gli1 and Gli2 (Park et al., 2000; Aza-Blanc et al.,
2000; Bai and Joyner, 2001). Gli2 and Gli3 may also share
overlapping functions in foregut, lung, tooth, and skeletal
development (Mo et al., 1997; Motoyama et al., 1998;
Hardcastle et al., 1998). On the other hand, several lines of
evidence suggest that Gli2 and Gli3 may have unique and
redundant roles as repressors of transcription (Ruiz i Altaba,
1998, 1999; Sasaki et al., 1999; Aza-Blanc et al., 2000).
Additionally, recent biochemical data suggest a role for
Gli3 in mediating the transcriptional activating function of
Gli1 (Dai et al., 1999). The tightly woven activities of the
three Gli proteins challenge efforts to tease out the contri-
bution of each Gli in the transcriptional response to hedge-
hog signaling.
Our present data demonstrate a requirement for Shh
signaling in prostate ductal morphogenesis. From an initial
uniform distribution in the UGE, Shh expression localizes
to clusters of epithelial cells that form the nascent prostate
buds in response to testosterone stimulation. The focal
expression of Shh in the prostatic buds is mirrored by
localized expression of Ptc1, Gli1, and Gli2 in the surround-
ing ductal mesenchyme. Exogenous SHH peptide acts di-
rectly on the UGM to induce the expression of Gli1 (and
Ptc1) but not Gli2 and Gli3 expression. However, inhibition
of Shh signaling by the plant alkaloid cyclopamine leads to
a coordinate, dose-dependent inhibition of Gli gene expres-
sion (Gli1Gli2Gli3) which is accompanied by a dose-
dependent inhibition of prostate ductal budding.
MATERIALS AND METHODS
Tissue Collection
Urogenital sinus and adult prostate tissues were obtained from
CD-1 mice (Charles River Laboratories). Day of vaginal plug
was designated embryonic day 0 (E0) and day of birth was desig-
nated P1. Tissues were dissected as previously described (Oefelein
et al., 1996; Podlasek et al., 1997) with the modification that, at
E13 and E15, the line of division between the prostatic anlagen and
the distal urethra was advanced cranially so as to specifically
isolate that region of the UGS destined to undergo ductal budding
and to minimize the inclusion of nonbudding distal urethra.
Separation of UGE and UGM tissues from intact E16 urogenital
sinus was performed as described previously (Cunha and Donja-
cour, 1987).
RNA Isolation and RT-PCR
Total RNA was isolated from either pooled or individual speci-
mens by using the TRIzol method (Life Technologies) as described
previously (Podlasek et al., 1997). Semiquantitative RT-PCR was
performed with 35 or 40 cycles of amplification (Applied Biosys-
tems RT-PCR Core Kit). Reactions were routinely performed
without reverse transcriptase to demonstrate RNA dependence of
the reaction products. Quantitative RT-PCR (QRT-PCR) was per-
formed by determining the ratio between the products for the gene
of interest and for ribosomal subunit RPL-19 that was used as an
endogenous gene internal standard. RT-PCR was performed over a
range of cycle number (22–32 cycles) on 50 ng of total RNA as
described previously (Podlasek et al., 1999). Densitometry of the
photographed gel was performed by using the Bio-Rad Molecular
Analyst. The log of band density versus cycle number was plotted,
and the ratio of the products within the linear range was deter-
mined. The sizes of the various gene products were: RPL-19, 556
bp; Shh, 260 bp; Gli1, 291 bp; Gli2, 273 bp; Gli3, 220 bp; Ptc1, 228
bp; Bmp4, 235 bp; Hoxd-13, 234 bp; and FGF1, 150 bp.
RT-PCR primer sequences 5–3were: RPL-19 antisense, GACA-
GAGTCTTGATGATCTC; RPL-19 sense, TCAGGCTACAGAA-
GAGGCTT; Shh antisense, ACTGCTCGACCCTCATAGTG; Shh
sense, GGCAGATATGAAGGGAAGAT; Gli1 antisense, TGTG-
GCGAATAGACAGAGGT; Gli1 sense, TGCCAGATATGCTTC-
AGCCA; Gli2 antisense, CTGGCCATAGTAGTATAGCG; Gli2
sense, TTCATGGAGTCCCAGCAGAA; Gli3 antisense, TGAAG-
CATCTGTGGAGATGG; Gli3 sense, AAGTGACCTGTCAGGT-
GTAG; Ptc1 antisense, GTCTCAGGGTAGCTCTCATA; Ptc1
sense, GCATTCTGGCCCTAGCAATA; Bmp4 antisense, TCCA-
GGAACCATTTCTGCTG; Bmp4 sense, CACTGTGAGGAGTT-
TCCATC; Hoxd-13 antisense, GACAGTGTCTTTGAGCTTGG;
Hoxd-13 sense, TTAAACCAGCCGGACATGTG; FGF1 antisense,
GATGGCTTTCTGGCCATAGT; and FGF1 sense, GAGGAAT-
GTCTGTTCCTGGA.
Whole-Mount in Situ Hybridization
In situ hybridization of 4% paraformaldehyde-fixed urogenital
tissues was performed according to previously described protocol
(Wilkinson, 1992; Lamm et al., 2001). Briefly, tissues were bleached
with 6% hydrogen peroxide (60 min), digested with 10 g/ml
proteinase K (15 min), and refixed in 0.2% glutaraldehyde/4%
paraformaldehyde (20 min) at room temperature. Hybridization
with digoxigenin-labeled RNA probes was performed at 70°C for
16 h. Following high stringency washes and RNase treatment,
tissues were incubated with an alkaline phosphatase-coupled anti-
digoxigenin antibody (Roche Molecular Biochemicals) for 16 h at
4°C. The color reaction was developed by using nitroblue tetrazo-
lium and 5-bromo-4-chloro-3-indolyl phosphate as substrates.
Some stained tissues were incubated in 50% sucrose/phosphate-
buffered saline (PBS) solution at 4°C overnight, embedded in
Tissue-Tek OCT compound, and cryosectioned at 15 m.
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Probe Synthesis
A full-length (2.6 kb) cDNA encoding mouse Shh cloned into
pBluescript II SK and a 841-bp EcoRI cDNA fragment encoding
mouse Ptc1 cloned into pBluescript II KS were generously pro-
vided by M. Scott (Howard Hughes Medical Institute, Stanford
University School of Medicine, CA; Goodrich et al., 1996). Cloned
cDNA for mouse Gli1 (1.7 kb), mouse Gli2 (1.9 kb), and mouse Gli3
(0.8 kb) were kindly provided by A. Joyner (Skirball Institute of
Biomolecular Medicine, NY University School of Medicine; Hui
and Joyner, 1993; Grindley et al., 1997). All plasmids were CsCl-
purified and linearized as follows: Shh with EcoRI (antisense) and
XhoI (sense), Gli1 with NotI (antisense), Gli2 with KpnI (antisense)
and HindIII (sense), Gli3 with HindIII (antisense) and XbaI (sense),
and Ptc1 with BamHI (antisense) and HindIII (sense). Probes were
prepared by using a DIG RNA labeling kit (Roche Molecular
Biochemicals) and appropriate T7 and T3 RNA polymerases. Con-
centrations of antisense and sense riboprobes, quantitated by
spotting dilutions on nitrocellulose paper along with control DIG-
RNA, were 5 g/l.
In Vitro Organ Culture
Culture of male or female UGS obtained at E14 was performed as
previously described (Lamm et al., 2001). Briefly, tissues were
isolated from the bladder, distal urethra, Wolffian and Mullerian
ducts, and transferred to 0.4-m Millicell-CM filters (Millipore
Corp.) placed inside six-well tissue plates. Each well contained 1.5
ml serum-free DMEM:Ham’s F-12 (1:1) supplemented with 2% ITS
(Collaborative Biomedical Products), 25 g/ml gentamycin, 0.25
g/ml amphotericin B, and 108 M dihydrotestosterone (DHT). In
DHT-free media, ethanol was added to a final concentration of
0.1%. Cultures were maintained in a humidified 37°C, 5% CO2
incubator.
DHT Experiments
The effect of testosterone on Shh expression and morphogenesis
in female E14 UGS was determined by maintaining explants in
serum-free media in the presence of 108 M dihydrotestosterone
(DHT) or 0.1% ethanol control. After 3 days in culture, tissues were
processed for whole-mount in situ hybridization.
Exogenous SHH Experiments
The effect of exogenous SHH on gene expression was examined
in both intact UGS and separated UGE and UGM tissue layers. CM
Affi-Gel Blue beads (100–200 m diameter; Bio-Rad) were incu-
bated at 37°C for 1 h in either SHH (67 M of the active N-terminal
peptide of recombinant human SHH protein; Curis, Inc., Cam-
bridge, MA) or 0.03% BSA as control. Intact E14 male UGS were
implanted with either BSA- or SHH-soaked beads (1–3 beads/UGS).
Tissues were then cultured in serum-free, DHT-free media for 2
days, then processed for whole-mount in situ hybridization.
In other experiments, intact E14 male UGS and separated UGE
and UGM tissue layers obtained from intact E16 UGS were
cultured separately in serum-free, DHT-free media in the absence
or presence of exogenous SHH (5 M of the active N-terminal
peptide of recombinant human SHH protein). Intact UGS were
maintained in culture for 3 days, while separated UGE and UGM
tissues were cultured for 1 day. At the end of culture, tissues were
processed for RT-PCR analysis.
Shh Antibody Experiments
To neutralize Shh biological activity, E14 male UGS were
cultured in serum-free, DHT-supplemented media in the presence
of 50 g/ml of the 5E1 monoclonal antibody developed against the
biologically active amino-terminal fragment of Shh (Developmen-
tal Studies Hybridoma Bank, University of Iowa, Iowa City, IA).
The 5E1 antibody has been previously shown to block Shh-
mediated induction of floor plate cells and motor neurons (Ericson
et al., 1996) and to downregulate Ptc1 expression and epithelial cell
proliferation in developing tooth germs (Cobourne et al., 2001).
Control incubation was done in the presence of 50 g/ml of
purified mouse IgG (Sigma-Aldrich, Inc.). Cultures were main-
tained for 7 days, with media changes every 2 days. Tissues were
photographed and then processed for RT-PCR analysis. Quantita-
tion of ductal budding was performed as previously described
(Lamm et al., 2001).
Cyclopamine Experiments
To inhibit Shh signaling, E14 male UGS were cultured in vitro in
the presence of cyclopamine, a steroidal alkaloid from the Vera-
trum plant species. Cyclopamine (or the control analog, solanidine)
was dissolved in 95% ethanol and diluted with serum-free, DHT-
supplemented media to a final concentration of 1–10 M. For some
control experiments, the vehicle ethanol was added to the media to
a final concentration of 0.1%. Cyclopamine and solanidine were
generous gifts from W. Gaffield (Western Regional Research Cen-
ter, USDA, Albany, CA). Cultures were maintained for either 3 or
7 days, with media changes every 2 days. Tissues were photo-
graphed for quantitation of ductal budding (Lamm et al., 2001) and
then processed for RT-PCR analysis or whole-mount in situ hy-
bridization.
BrdU Labeling for Cell Proliferation
The effect of chemical inhibition of Shh signaling on cell
proliferation was assessed in E14 UGS tissues cultured in vitro for
7 days in the absence or presence of 10 M cyclopamine (0.1%
ethanol as control). During the last 4 h of culture, tissues were
incubated with bromodeoxyuridine (BrdU) labeling reagent accord-
ing to manufacturer’s protocol (Roche Molecular Biochemicals).
BrdU uptake in formalin-fixed sectioned tissues was visualized
with anti-BrdU-alkaline phosphatase-conjugated antibody. For
quantitative analysis of BrdU staining, we examined three 4-m-
thick sections from each of three control and cyclopamine-treated
tissues. The three tissues from each group were selected at random
for analysis to avoid bias. For each section scored, BrdU-labeled
epithelial and mesenchymal cells were counted within three to five
high power visual fields at 40 magnification (each field with an
area of 1.4 mm2). The total number of epithelial and mesenchymal
nuclei was determined from adjacent sections stained with hema-
toxylin and eosin. The veracity of epithelial versus mesenchymal
designations has been confirmed previously by staining of adjacent
sections with vimentin (Lamm et al., 2001). BrdU labeling indices
(number of stained nuclei/total number of nuclei counted  %
labeled) were calculated. Data were analyzed by using generalized
linear models with correlated data structure (Liang and Zeger,
1986) and the SAS statistical software (SAS Institute Inc., 1999).
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RESULTS
Shh Expression Localizes to Prostate Epithelial
Buds
The time course of Shh expression in the developing
prostate was determined by quantitative RT-PCR analysis
(Fig. 1A). Shh expression was present at the earliest time
point examined (E13) and was maximal at E16, just prior to
the onset of ductal budding. Expression diminished postna-
tally and gradually declined to a low but detectable level in
the adult prostate. The apparent upregulation in Shh ex-
pression from the prebudding to budding stage followed by
downregulation in expression in the adult prostate is simi-
lar to our earlier findings; however, the degree of upregula-
tion observed here is less than previously reported (Pod-
lasek et al., 1999). This results from a more rigorous
isolation of the prebudding UGS to include specifically that
region destined to undergo bud formation. Whole-mount in
situ hybridization revealed only faint staining for Shh
expression at E15 (Fig. 2A). However, cut sections of whole-
mount specimens revealed Shh expression uniformly dis-
tributed throughout the epithelium that lines the urethral
lumen (Fig. 2B). This strong staining in the UGE was poorly
visualized in the E15 whole-mount preparation presumably
due to the thickness of the surrounding mesenchymal layer.
The strict epithelial localization of Shh staining echoes the
stringent localization of Shh mRNA by RT-PCR to the E16
UGE and the epithelial localization of the Shh protein by
immunostaining (Podlasek et al., 1999). At E17, staining for
Shh expression in the whole-mount specimens began to
localize to areas of the UGS where budding occurs (Fig. 2C).
On cut sections, expression became focused in clusters of
epithelial cells that had evaginated into the surrounding
mesenchyme (Fig. 2D). While expression concentrated at
these sites of nascent bud formation, expression diminished
in the remainder of the luminal epithelium (Fig. 2D). At
E18, Shh expression became more restricted to sites of
incipient budding (not shown). By P1, foci of Shh expression
were more pronounced and distinct and they corresponded
to the primary ducts of the anterior prostate or coagulating
gland, dorsal prostate, and ventral prostate (Figs. 2E and
2G). Sections of P1 specimens showed regional heterogene-
ity in the distribution of Shh expression in the developing
ducts. Shh expression was strongest in the advancing distal
regions of the ducts (tips) and was relatively diminished in
the proximal duct segments and in the luminal epithelium
(Fig. 2F).
Prostate ductal budding is a testosterone-induced event
that exemplifies the pivotal role played by testosterone in
determining the developmental fate of the UGS. In the
absence of testosterone, both male and female UGS undergo
vaginal differentiation. In the presence of testosterone, on
the other hand, both male and female UGS exhibit prostate
ductal development (Cunha et al., 1980). We have shown
previously that androgen stimulation increases Shh expres-
sion (Podlasek et al., 1999). We postulated that androgen
regulation of Shh expression might be a key element in the
induction of prostate budding. Noting the dynamic changes
in the pattern of Shh expression that accompanied ductal
budding in the male, we predicted that culture of the female
UGS in the presence of testosterone would not only in-
crease Shh expression but also induce similar changes in
Shh localization. If so, this would suggest an important
functional linkage between testosterone action and Shh
expression in the ductal budding process. To investigate
this relationship, E14 female UGS tissues were cultured for
3 days in the absence or presence of dihydrotestosterone
(DHT) and processed for whole-mount in situ hybridization
to localize Shh expression. In tissues cultured in the ab-
sence of DHT, diffuse Shh expression was limited to the
cranial aspect of the female UGS (Fig. 3A). These results are
consistent with our observations on whole-mount staining
of the E17 female UGS (unpublished data) and our finding in
the female human fetus that Shh expression is highest in
the cranial UGS (Barnett et al., 2002). In the presence of
DHT, intense Shh expression was seen to extend caudally
and to be strongly focused in the epithelial buds that formed
in response to testosterone stimulation (Figs. 3B and 3C).
The Urogenital Sinus Mesenchyme Is a Target of
Shh Signaling
Since Shh exerts its actions through binding to the Shh
receptor, Ptc1, and modulating the activity of members of
the Gli gene family, we examined the localization and
expression of these genes in the UGS. Localization of gene
expression to the epithelium and/or mesenchyme of the
UGS was determined by RT-PCR assay of RNA prepared
from the separated tissue layers of the UGS at the prebud
stage (E16). As we have previously shown (Podlasek et al.,
1999; Lamm et al., 2001), Shh expression was exclusively
epithelial (Figs. 4A and 4B, lane 1). Ptc1 was expressed in
both the mesenchyme and epithelium (Figs. 4A and 4B, lane
2). Gli1, Gli2, and Gli3 were all expressed predominantly in
the mesenchyme (Fig. 4B, lanes 3–5). The faint product band
for Gli1 that was also observed in the separated epithelial
layer might indicate a low level expression of Gli1 in the
epithelium (Fig. 4A, lane 3). A Gli2 product band in the
epithelial layer was not seen in the experiment shown (Fig.
4A, lane 4), but was seen in reactions run at a greater cycle
number (40 vs 35 cycles; Fig. 4A, lane 7). We have consis-
tently observed similar faint epithelial product bands with
other primarily mesenchymal genes such as Bmp4 (Figs. 4A
and 4B, lane 6; Lamm et al., 2001). The best explanation for
this observation is that our epithelial preparations are
contaminated by a minor component of mesenchymal cells.
Gli3 also appeared to be expressed predominantly in the
mesenchyme, but in this case, there was a stronger sugges-
tion of epithelial expression as well (Figs. 4A and 4B, lane 5).
Gli1, Gli2, and Gli3 all displayed a time course of
expression similar to that of Shh (Figs. 1B–1D). The ob-
served similarity is not a trivial consequence of the method
of analysis since unrelated genes such as Bmp7 exhibited a
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dramatically different time course (Fig. 1A, inset). Thus,
Shh, Gli1, Gli2, and Gli3 display a coordinate increase in
expression prior to the initiation of ductal budding, remain
elevated during the period of ductal budding, and decline
postnatally to low but detectable levels in the differentiated
adult prostate.
Whole-mount in situ hybridization revealed that all three
Gli genes and Ptc1 were expressed diffusely in the UGS at
E15, prior to onset of ductal budding (data not shown). As
budding commenced, expression of Ptc1, Gli1, and Gli2
became progressively focused to areas surrounding the
nascent prostatic ducts, forming “rings” of expression
around sites of budding by P1 (Figs. 5A, 5C, and 5E).
Sections of whole-mount specimens revealed concentration
of Ptc1, Gli1, and Gli2 expression in the mesenchyme
immediately surrounding epithelial buds with diminishing
expression in mesenchyme further from the buds (Figs. 5B,
5D, and 5F). In contrast, Gli3 expression was diffusely and
weakly expressed throughout the UGS, although a stronger
staining was often seen around the coagulating gland (Fig.
5G). The diffuse distribution of Gli3 expression was further
apparent in cut sections of whole-mount specimens that
showed expression throughout the UGM as well as in
epithelial buds, though not in the epithelial lining of the
urethral lumen (Fig. 5H). Our staining for Gli3 expression
was validated by whole-mount in situ hybridization of E11
mouse limbs (data not shown) that replicated the Gli3
staining pattern reported by Buscher and Ruther (1998).
The localization of Gli1 and Gli2 expression around sites
of budding occurs coincident with the focusing of epithelial
Shh expression in these buds and mimics the expression of
Ptc1. Since Ptc1 is a target of Shh and its expression is
considered a reliable indicator of Shh signaling (Marigo and
Tabin, 1996; Marigo et al., 1996b), these findings suggest an
inductive relationship between Shh expression by the epi-
thelium and mesenchymal Gli1 and Gli2 expression. The
relationship of Shh signaling to the expression of the Gli
genes and the transcriptional activity of their products,
however, is complex. Shh is generally found to induce Gli1
expression (Hynes et al., 1997; Sasaki et al., 1997; Lee et al.,
1997; Dai et al., 1999). Thus, like Ptc1, the upregulation of
Gli1 expression is diagnostic of an active Shh signaling
pathway in many systems. Shh has also been shown to
induce Gli2 expression in the frog neural plate (Ruiz i
Altaba, 1998). Gli3 is a target of transcriptional repression
by Shh (Marigo et al., 1996a; Ruiz i Altaba, 1998); however,
the trans-activating function of Gli3 is positively regulated
by Shh (Dai et al., 1999).
To examine the inductive and/or dependent relationship
between Shh signaling and expression of the three Gli genes
in the developing prostate, we tested the effect of exogenous
SHH peptide on Gli gene expression in the UGS cultured in
vitro for 2 days. Since testosterone exerts a trophic effect on
Shh expression (Podlasek et al., 1999), culture was per-
formed in the absence of testosterone to minimize endoge-
nous Shh expression. E14 male UGS were implanted with
Affi-Gel beads soaked in either recombinant human SHH
FIG. 1. Time course of gene expression in the developing and adult
prostate determined by quantitative RT-PCR with RPL-19 mRNA as an
internal standard: (A) Shh, (B) Gli1, (C) Gli2, and (D) Gli3. Figure inset
in (A) shows Bmp7 expression at selected time points. Each bar repre-
sents the mean  SEM of triplicate assays of RNA from pooled tissues.
The time points in the horizontal axis are grouped into three stages of
prostate morphogenesis: prior to morphological evidence of bud for-
mation in the urogenital sinus (prebudding), appearance of primary
buds (budding), and continued formation of primary buds and appearance
of secondary/tertiary ductal branches (budding/branching).
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FIG. 2. (Left) Schematic illustration of prostate morphogenesis from E15 to P1. (Right) Localization of Shh expression by whole-mount in situ
hybridization. Staining is not apparent in the intact E15 whole-mount specimen (A), but (B) reveals strong staining in epithelial cells (e) lining the lumen
of the urethra (u). Strong staining for Shh expression is evident in the intact E17 specimen (C), and (D) shows expression concentrated in clusters of
epithelial cells (arrows) that have penetrated into the surrounding mesenchyme (m). Weaker staining is present in the rest of the epithelial layer
(arrowheads). At P1 (E, G), Shh expression is focused to the nascent buds of the dorsal prostate (dp), anterior prostate or coagulating gland (cg), and ventral
prostate (vp). Some staining is also observed in the seminal vesicle (sv). Sections of P1 specimens (F, H) show that Shh expression in the epithelial cells
(e) of prostate buds is greater in the distal aspect of the bud (arrow) than in the proximal duct segment (arrowhead). Staining is also no longer apparent
in the epithelial lining (e*) of the urethral lumen. Slight nonspecific blue staining is seen at the luminal surface of the epithelial lining. The epithelial
and mesenchymal designations were confirmed by immunostaining for the mesenchyme-specific marker vimentin (not shown; Lamm et al., 2001). No
staining is seen in whole-mount specimens hybridized with Shh sense probe (data not shown). Data are representative of three to six specimens per time
point analyzed. ugs, urogenital sinus; b, bladder; t, testis; ur, ureter. (B, D, H) Coronal sections oriented perpendicular to the axis of the prostatic urethra.
(F) An oblique section oriented nearly parallel to the axis of the coagulating gland that also crosses the urethra. Scale bar, 500 m for (A), (C), (E), and
(G); 20 m for (B), (D), (F), and (H).
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peptide or BSA control and cultured in vitro in the absence of
DHT. A strong inductive effect of SHH on Gli1 expression
was evident by whole-mount in situ hybridization analysis
(Figs. 6A and 6B). On the other hand, staining around the
SHH-soaked beads increased only slightly for Gli2 and Gli3
expression (Figs. 6C and 6D and 6E and 6F, respectively).
FIG. 3. Effect of testosterone on Shh expression. E14 female urogenital sinus tissues were cultured in the absence or presence of 108 M
dihydrotestosterone (DHT) for 3 days. In the absence of DHT (A), Shh expression (arrow) is localized to the cranial margin of the urogenital
sinus. In the presence of DHT (B, C), Shh expression extends caudally and is focused in the bud outgrowths (arrowheads, C) that are induced
by androgen stimulation. Photo in (C) is a magnified image of bordered area in (B). u, urethra. Scale bar, 600 m. Data are representative
of two to three tissues per group.
FIG. 4. Semiquantitative RT-PCR for gene expression in separated UGE (A) and UGM (B) obtained from male E16 urogenital sinus tissues.
Assay was performed at 35 cycles on RNA from pooled samples using primers for both RPL-19 (as internal standard; arrows) and either Shh
(lane 1, 260 bp), Ptc1 (lane 2, 228 bp), Gli1 (lane 3, 291 bp), Gli2 (lane 4, 273 bp), Gli3 (lane 5, 220 bp), or Bmp4 (lane 6, 235 bp). Faint message
for Gli2 was evident in the UGE when reaction was done at 40 cycles (Fig. 4A, lane 7). Reactions performed in parallel without reverse
transcriptase demonstrated the RNA dependence of the reaction products (data not shown).
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To quantitatively examine the inductive effect of exog-
enous SHH on Gli gene expression, E14 male UGS were
cultured in the absence of DHT with or without SHH
peptide added to the culture medium. QRT-PCR analysis of
gene expression after 3 days of culture demonstrated a
significant induction of Ptc1 expression by exogenous SHH
that was paralleled by an equally strong induction of Gli1
expression (Figs. 7A and 7B). Slight increases in Gli2 and
Gli3 expression suggested, at most, a weak inductive effect
of SHH on expression of these genes (Figs. 7C and 7D). This
is in agreement with our preceding results using SHH-
soaked beads on intact UGS. To determine whether the
inductive effect of SHH on Gli1 (and Ptc1) expression is a
result of direct action on mesenchymal target cells or
requires reciprocal signaling between the epithelium and
mesenchyme, we separated the UGE and UGM at E16, prior
to the onset of ductal budding, and cultured the UGM
without DHT in the presence or absence of exogenous SHH.
QRT-PCR analysis of expression revealed dramatic induc-
tion of Ptc1 and Gli1 expression in the UGM, confirming a
direct inductive effect by SHH (Figs. 7E and 7F). No induc-
tion of Gli2 or Gli3 expression was observed (Figs. 7G and
7H). Essentially identical results were obtained when the
UGM was cultured with DHT in the presence or absence of
exogenous SHH (data not shown). We considered the pos-
sibility that SHH might induce Gli3 (or Gli2) expression in
the UGE. To examine this possibility, we cultured E16
UGE without DHT in the presence or absence of exogenous
SHH peptide. This showed no induction in expression of
any of the three Gli genes (data not shown). Altogether,
these findings suggest that SHH acts directly to induce Gli1
expression in the UGM but does not exert a direct inductive
effect on expression of either Gli2 or Gli3. However, this
does not exclude the possibility that the slight increases in
Gli2 and Gli3 expression observed when the intact UGS is
cultured with exogenous SHH might arise by indirect
mechanisms dependent on the presence of both tissue
layers.
Inhibition of Shh Signaling Coordinately Inhibits
Gli Gene Expression and Ductal Budding
Neutralization of Shh function with the polyclonal anti-
body Ab80 (Marti et al., 1995) abrogates growth and glan-
dular morphogenesis in the UGS grafted under the renal
capsule of an intact male host (Podlasek et al., 1999).
However, the grafting procedure disrupts UGS morphology
and makes it difficult to distinguish an effect on ductal
budding from an effect on glandular morphogenesis. To
circumvent this limitation, we used an in vitro UGS
explant culture system that preserves the process of ductal
budding and allows us to quantitate effects on budding by
counting the number of visible buds (Lamm et al., 2001).
E14 male UGS tissues were cultured in vitro for 7 days in
the presence of 50 g/ml anti-Shh monoclonal antibody,
5E1 (Ericson et al., 1996), or IgG control. The presence of
the antibody caused a significant decrease (30%; P  0.018)
in the mean number of duct tips in cultured rudiments.
This was accompanied by a small but significant decrease
(36%; P  0.015) in Gli1 expression. Gli2 and Gli3 expres-
sion were also slightly diminished (29 and 17%, respec-
tively), but the differences were not statistically significant.
Expression of genes outside the hedgehog pathway, such as
FGF1, was unchanged (data not shown).
More stringent inhibition of Shh signaling has been
accomplished in many organ systems through the use of the
plant steroidal alkaloid, cyclopamine (Incardona et al.,
1998; Cooper et al., 1998; Kim and Melton, 1998; Chiang et
al., 1999; Sukegawa et al., 2000; Dahmane et al., 2001; Van
Den Brink et al., 2001). Cyclopamine appears to act by
altering the interaction between components of the Ptc1–
Smo receptor complex (Taipale et al., 2000). E14 male UGS
tissues cultured for 3 days in the presence of 10 M
cyclopamine showed a dramatic loss of Gli1 expression by
whole-mount in situ hybridization (Figs. 8A and 8B). Gli2
and Gli3 expression also appeared decreased, though not
completely abolished, by cyclopamine (Figs. 8C–8F). To
quantitatively determine the effects on gene expression,
E14 male UGS were cultured in vitro for 7 days in the
presence of 10 M cyclopamine or ethanol vehicle control
and assayed for gene expression by QRT-PCR. To demon-
strate the specificity of the cyclopamine effect, some UGS
tissues were cultured in the presence of 10 M solanidine,
a related steroidal alkaloid (Gaffield and Keeler, 1996).
Cyclopamine (but not solanidine) inhibited Shh signaling in
UGS tissues as evidenced by the dramatic decrease in Ptc1
expression relative to control tissues (Fig. 9A). This was
accompanied by nearly complete inhibition of Gli1 expres-
sion (Fig. 9B). In addition, there was a significant inhibition
of both Gli2 and Gli3 expression, though certainly not as
FIG. 5. Localization of gene expression in the male P1 urogenital sinus. Whole-mount in situ hybridization reveals focused domains of Ptc1 (A),
Gli1 (C), and Gli2 (E) expression surrounding the nascent buds of the dorsal prostate, coagulating gland, and ventral prostate. Comparable areas
of localized Ptc1, Gli1, and Gli2 expression ringing buds of the lateral division of the dorsal prostate are indicated (arrows: A, C, E). Staining for
Gli1 is also present in the seminal vesicles (sv). Sectioning confirms the expression of Ptc1, Gli1, and Gli2 localized to the mesenchyme (m)
surrounding the epithelial buds (e; B, D, F). Staining for Gli3 expression is consistently weak and diffuse (G), although we occasionally observe
some concentration of expression surrounding the developing coagulating gland (arrow). Sectioning (H) confirms the diffuse pattern of Gli3
expression in the mesenchyme (m). There is weak staining of the epithelium (e) of prostatic buds as well but no specific staining of the epithelium
(e*) lining the urethral lumen (u). No staining is seen in whole-mount specimens hybridized with appropriate sense probes (data not shown). Scale
bar, 500 m for (A), (C), (E), and (G); 20 m for (B), (D), (F), and (H). Data are representative of 5–11 specimens per gene analyzed.
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severe as that of Gli1 (Figs. 9C and 9D). Cyclopamine did
not inhibit the expression of either Shh or Hoxd-13 (Figs. 9E
and 9F). The apparent increase in Shh expression in this
experiment was not reproducible.
The effect of cyclopamine on Gli2 and Gli3 expression
echoed the mild decrease in Gli2 and Gli3 expression
observed with 5E1 antibody blockade. To further define this
observation, we examined the concentration dependence of
the cyclopamine effect on expression of the three Gli genes
(Figs. 10A–10C). Gli1, Gli2, and Gli3 all exhibited a
concentration-dependent inhibition of expression by cyclo-
pamine. However, there was a clear suggestion of a graded
FIG. 6. Induction of Gli expression by exogenous SHH. E14 male urogenital sinus tissues were implanted with Affi-Gel Blue beads soaked
in either 0.03% BSA (control) or 67 M recombinant human SHH peptide. Following culture for 2 days in serum-free, DHT-free media,
whole-mount in situ hybridization for Gli1, Gli2, and Gli3 was performed. Pronounced staining for Gli1, but only slight staining for Gli2
and Gli3, message in the urogenital sinus implanted with SHH-soaked beads was evident compared with control (compare A with B, C with
D, and E with F). The foci of color on the rim of the control specimen shown in (C) is nonspecific staining. The sites in specimens where
beads were located prior to being dislodged during the stain development process are indicated (*). Scale bar, 500 m.
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effect: Gli1Gli2Gli3. This apparent hierarchy further
strengthens the suggestion that inhibition of Shh signaling
(either via antibody or cyclopamine inhibition) diminishes
expression of all three Gli genes. Taken together with our
finding that Shh induces only Gli1 expression in the iso-
lated UGM, it suggests that Shh signaling may positively
regulate Gli2 and Gli3 expression through indirect mecha-
nisms.
Downregulation of Gli gene expression by cyclopamine
was accompanied by a marked inhibition of ductal budding.
Whereas tissues cultured in the absence of cyclopamine
displayed multiple buds (Fig. 11A), budding in the presence
of 10 M cyclopamine was severely compromised (Fig.
11B). To quantitate the effect, the influence of varying
concentrations of cyclopamine on the number of discern-
ible duct tips was determined. Cyclopamine inhibited duc-
tal budding in a dose-dependent fashion. There was a 71%
reduction in mean number of duct tips in the presence of 10
M cyclopamine relative to the control (Fig. 11C). Control
experiments using the related alkaloid solanidine (10 M)
showed no inhibition of ductal budding (data not shown).
To determine whether the inhibition of budding was asso-
ciated with changes in cell proliferation, BrdU incorpora-
tion was compared between tissues treated with 10 M
cyclopamine or ethanol vehicle control. Labeling indices for
the epithelium and mesenchyme were calculated from the
number of BrdU-labeled stained nuclei/total number of
nuclei counted in representative visual fields of tissue
sections (Table 1). The specimens selected for analysis, as
well as the individual sections and visual fields, were
selected at random and scored by a blinded observer to
avoid bias. This analysis revealed a 30% decrease in the
mesenchymal labeling by cyclopamine (P 	 0.0001). An
even greater effect was observed on the epithelial labeling,
which was decreased by 50% in the presence of cyclopam-
ine (P 	 0.0001). These results suggest that Shh signaling is
linked to proliferation of both the epithelium and mesen-
chyme during prostate development.
DISCUSSION
The previously identified requirement for Shh in prostate
development (Podlasek et al., 1999) is linked by our present
data specifically to the process of prostate ductal bud
formation. An initial uniform distribution of Shh expres-
FIG. 7. Effect of exogenous SHH on gene expression in intact UGS (I) and isolated UGM (II). Intact E14 male UGS and isolated E16 UGM
were cultured separately in serum-free, DHT-free media in the absence (open bars) or presence (filled bars) of 5 M recombinant human
SHH peptide for 72 and 24 h, respectively. QRT-PCR for Ptc1 (A, E), Gli1 (B, F), Gli2 (C, G), and Gli3 (D, H) was performed utilizing RPL-19
mRNA as an internal standard. Each bar represents the mean  SEM of triplicate assays of RNA from pooled tissues (n  10 intact UGS
tissues per group; n  12 isolated UGM tissue layers per group).
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sion throughout the UGE yields to a more focused expres-
sion in the subset of epithelial cells that evaginate into the
surrounding mesenchyme to form prostate buds. This spa-
tial localization is associated with a functional requirement
for Shh signaling in bud formation. Both antibody neutral-
ization of Shh function and chemical inhibition of Shh
signaling inhibit ductal budding. Chemical inhibition by
cyclopamine caused a more drastic effect as evidenced by
the almost complete downregulation of Ptc1 and Gli1
expression accompanied by a severe inhibition of budding.
These data indicate that Shh signaling is obligatory for the
formation of the prostate ductal bud.
Androgens are required for prostate development (Cunha
et al., 1987, 1992). Testosterone secreted by the fetal testes
is converted to 5 -dihydrotestosterone (DHT) in the UGS.
DHT is considered to be the major active androgen that
promotes prostate morphogenesis (Cunha et al., 1987; Tsuji
et al., 1994) and embryonic male and female rodent UGS
cultured in vitro form prostatic buds in the presence of
DHT (Lasnitzki and Mizuno, 1977). DHT upregulates Shh
expression in both male and female UGS (Podlasek et al.,
1999); however, Shh expression is not strictly androgen-
dependent. Shh is expressed (albeit at lower levels) in
female UGS (Podlasek et al., 1999; Barnett et al., 2002) and
in UGS of Tfm mice that are insensitive to androgens due to
a frameshift mutation of the androgen receptor (Charest et
al., 1991; Barnett et al., 2002). But, as shown here, DHT
dramatically influences the localization of Shh expression.
Shh is expressed at the cranial margin of the female UGS
cultured without DHT, but in association with DHT-
induced budding, Shh expression extends caudally and
concentrates to the nascent buds in a fashion that mimics
the relocalization of Shh expression at the onset of bud
formation in the male. These data therefore suggest that
DHT activates a male-specific spatial pattern of Shh expres-
sion. Precedent for such a relationship exists in the appar-
ent androgen-dependent pattern of Bmp4 expression in the
developing prostate (Lamm et al., 2001). Other steroid
hormones have also been implicated in specifying gene
expression patterns (Ma et al., 1998). The effect of testos-
terone on Shh expression and the linkage of localized Shh
expression to ductal budding suggest that Shh acts down-
stream of androgen in the process of bud formation. How-
ever, Shh cannot promote ductal budding in the absence of
testosterone. When the male UGS was grown as a renal
subcapsular transplant in a castrated adult male host,
exogenous Shh activated Ptc1 and Gli1 expression, but did
not stimulate growth or glandular development (Podlasek
et al., 1999). This indicates that prostate ductal morphogen-
esis requires both testosterone and hedgehog signaling.
It is tempting to speculate that Shh initiates prostate
ductal bud formation. The focal expression of Shh to
epithelial sites of imminent prostate bud formation re-
sembles a similar restricted localization of Shh to the
epithelial thickening (placode) of the presumptive tooth or
follicle bud (Bitgood and McMahon, 1995; Iseki et al., 1996;
Oro et al., 1997; Jung et al., 1998; Morgan et al., 1998;
Zhang et al., 1999) or to the concentrated mesenchymal
Shh expression in the zone of polarizing activity (ZPA) in
the limb bud (Riddle et al., 1993). However, the proposition
that restricted expression of Shh to sites of budding is
necessarily indicative of its role in inducing bud formation
is a contentious issue. Recent data show morphologically
normal early formation of hair germs and limb buds in
Shh/ mutant mice, although later morphogenesis is
highly compromised (St. Jacques et al., 1998; Chiang et al.,
1999, 2001). These data have been interpreted to indicate
that initiation of bud formation is a prepatterned event and
that Shh is required for subsequent morphogenetic events
(St. Jacques et al., 1998; Chiang et al., 1999, 2001). On the
other hand, functional blockade of Shh signaling by either
the 5E1 anti-Shh antibody or PKA activator forskolin in
cultured mandibular arches prior to morphological onset of
odontogenesis inhibits the formation of tooth buds (Co-
bourne et al., 2001). Although our data demonstrate that
both the 5E1 antibody and cyclopamine inhibit prostate
ductal budding in UGS cultured at the prebud stage (E14),
they do not distinguish between a critical early role for Shh
in inducing budding versus an essential secondary role in
promoting epithelial outgrowth in response to the induc-
tion of budding by androgen.
It is interesting to note that the newborn female rat UGS
occasionally displays a small and variable number of
prostate-like epithelial buds (Thomson et al., 2002). This
has led to the speculation that budding by the urethral
epithelium is a constitutive or prepatterned event that is
activated by contact between the mesenchyme and epithe-
lium and accelerated by endocrine factors (Timms et al.,
1999; Thomson et al., 2002). In the male, the ductal buds
extend into an adjacent mesenchymal condensation (mes-
enchymal pad) and undergo extensive growth and branching
morphogenesis. It has been proposed that bud development
in the female is arrested by the presence of a thick smooth
muscle layer between the epithelial buds and the mesen-
chymal pad. Development of this smooth muscle layer is
attenuated in the presence of testosterone (Thomson et al.,
2002). Given the finding that Shh inhibits smooth muscle
differentiation in the wall of the fetal gut (Sukegawa et al.,
2000), it is possible that Shh could facilitate bud outgrowth
in the male by locally inhibiting smooth muscle differen-
tiation.
Shh expression is localized to the apical epithelial regions
of growing prostate buds, a domain that has been shown to
exhibit a high level of epithelial proliferative activity (Su-
gimura et al., 1986; Xue et al., 2001). This spatial pattern is
similar to the concentrated expression of Shh in the distal
epithelium of the developing buds of the tooth, hair,
feather, and lung (Urase et al., 1996; Bellusci et al., 1997;
Jung et al., 1998; Dassule et al., 2000; Miller et al., 2001). In
these organ systems, Shh has been linked to increased cell
proliferation that could promote bud elongation and growth
(Bellusci et al., 1997; Oro et al., 1997; Hardcastle et al.,
1998; Dassule et al., 2000; Cobourne et al., 2001). Our
observation that cyclopamine inhibition of Shh signaling
360 Lamm et al.
© 2002 Elsevier Science (USA). All rights reserved.
decreases both epithelial and mesenchymal cell prolifera-
tion in the UGS supports a mitogenic role for Shh in the
developing prostate that could involve autocrine and/or
paracrine mechanisms. Consistent with this observation,
genes that promote cell proliferation (e.g., cyclin D2) have
recently been identified as immediate downstream targets
of Gli1 (Yoon et al., 2002).
The asymmetric distribution of Shh expression within
the elongating prostate buds defines a proximodistal axis of
the developing duct. This regionalized expression, which
echoes similar findings in the developing hair/feather fol-
licle and in the developing lung (as discussed above), might
simply reflect a linkage to proliferation and growth. On the
other hand, regionalized Shh expression during embryonic
FIG. 8. Effect of cyclopamine on Gli gene expression. E14 male urogenital sinus tissues were cultured in DHT-supplemented, serum-free
media with or without 10 M cyclopamine for 3 days and then processed for whole-mount in situ hybridization for Gli1, Gli2, and Gli3
message. Staining for Gli1 RNA was dramatically downregulated by cyclopamine (A, B). Weak staining for Gli2 and Gli3 in the control
tissues also appeared to be diminished but still detectable in the presence of cyclopamine (C, D and E, F, respectively). Scale bar, 600 m.
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ductal morphogenesis may signal the early establishment of
a proximodistal heterogeneity in ductal morphology/
function of the prostate. In the adult prostate, the distal
duct segments exhibit a secretory epithelium of tall, colum-
nar cells within a thin fibroblastic stromal sheath while the
more proximal segments show a low, cuboidal epithelium
with a thicker, smooth muscle layer (Lee, 1997). Shh might
act to suppress smooth muscle differentiation in the more
distal duct segments, as it does in the developing gut
(Sukegawa et al., 2000). Shh might also be involved in
generating the asymmetric expression of Nkx3.1, a putative
Shh target, in the developing prostate duct (Sciavolino et
al., 1997). Whether Shh plays a primary role in establishing
the proximodistal axis in the developing prostatic duct
remains to be determined, but the pivotal role of Shh in
establishing polarity in the developing limb, neural tube,
somite, gut, and lung (Ingham and McMahon, 2001) is
consistent with such a global function.
The present data identify the UGM as the primary target
of Shh signaling. Although the gene for the Shh receptor,
Ptc1, is expressed in both the epithelium and mesenchyme,
all three Gli genes that encode the transcriptional media-
tors of Shh signaling are expressed predominantly in the
UGM. By whole-mount in situ hybridization, the Gli genes
show distinctly different spatial patterns of mesenchymal
expression relative to epithelial Shh expression. Gli1 is
tightly focused to the mesenchyme immediately surround-
ing epithelial expression of Shh in prostate buds. Gli2
expression also becomes progressively restricted to the
prebud mesenchyme but the localization does not appear to
be as tight as for Gli1. Gli3 remains diffusely expressed in
the UGM. Our data show that exogenous SHH peptide
FIG. 9. Quantitative analysis of cyclopamine effect on gene
expression. E14 male urogenital sinus tissues were cultured for 7
days in the presence of either 0.1% ethanol vehicle control (open
bars), 10 M cyclopamine (filled bars), or 10 M solanidine
(hatched bars). QRT-PCR for Ptc1 (A), Gli1 (B), Gli2 (C), Gli3 (D),
Shh (E), and Hoxd-13 (F) was performed utilizing RPL-19 mRNA as
an internal standard. Each bar represents the mean  SEM of
triplicate assays of RNA from pooled tissues (n 6 UGS per group).
*, P  0.02, relative to ethanol control group. Data are representa-
tive of two experiments.
FIG. 10. Dose-dependent inhibition of Gli gene expression by
cyclopamine. E14 male urogenital sinus tissues were cultured for 7
days in the absence or presence of varying concentrations of
cyclopamine (1–10 M) and assayed by QRT-PCR for Gli1 (A), Gli2
(B), and Gli3 (C) expression utilizing RPL-19 mRNA as an internal
standard. Each bar represents the mean  SEM of duplicate assays
of RNA from pooled tissues (n  5 tissues per dose). *, P 	 0.05
relative to 0 m cyclopamine control group.
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directly induces the expression of Ptc1 and Gli1 in the
isolated UGM, verifying that these are target genes of Shh
signaling in the embryonic prostate as they are in other
developing systems. Exogenous SHH did not induce expres-
sion of either Gli2 or Gli3 in the isolated UGM, but did
appear to induce a slight increase in the expression of both
Gli2 and Gli3 in the intact UGS. When the effect of
cyclopamine-mediated inhibition of Shh signaling on Gli
gene expression in the UGS was examined, we observed an
effect on all three Gli genes. There was dramatic inhibition
of Gli1 expression, but also a decrease, albeit less dramatic,
in the expression of Gli2 and Gli3. Taken together, these
observations suggest that Shh signaling directly induces
Gli1 expression in the UGM and may indirectly influence
the mesenchymal expression of Gli2 and Gli3 by mecha-
FIG. 11. Cyclopamine inhibits prostate ductal budding. E14 male urogenital sinus tissues were cultured for 7 days in the absence or
presence of varying concentrations of cyclopamine (1–10 M). Tissues were photographed and ductal budding was quantitated by scoring
of the photographed specimens. (A) Control tissues exhibited multiple prostatic buds with some evidence of ductal branching. In contrast,
tissues cultured in the presence of 10 M cyclopamine exhibited a severe inhibition of budding (B). Quantitative analysis of budding (C)
showed that cyclopamine significantly decreased the mean number of ductal tips in a concentration-dependent fashion. Each bar represents
the mean  SEM of at least 6 tissues per dose, except for 2.5 M, where n  3 tissues. *, P 	 0.05 relative to 0 m cyclopamine control
group. Scale for both (A) and (B), 200 m. u, urethra.
TABLE 1
Effect of Cyclopamine on Cellular Proliferation
Tissue Layer
Mean Labeling Index
PControl Cyclopamine (10 M)
Epithelium 11.90% 5.97%* 	0.0001
Mesenchyme 9.85% 6.85% 	0.0001
Note. E14 urogenital sinus tissues were cultured in vitro for 7
days in the absence or presence of 10 M cyclopamine. Ethanol
vehicle was used as control. During the last 4 h of culture, BrdU
labeling of tissues was done and labeling indices were determined.
Each mean labeling index was calculated from a total of 13 visual
fields (40 magnification) from 3 tissues for each group. The mean
labeling index in both the epithelium and mesenchyme of
cyclopamine-treated tissues was significantly decreased relative to
that of control (*, P 	 0.0001).
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nisms that involve an interaction between mesenchyme
and epithelium.
A near total loss of Gli1 expression accompanied the
dramatic inhibition of prostate bud formation by cyclopam-
ine. While Gli1 has been touted as the primary transcrip-
tional mediator of hedgehog signaling, numerous studies
point to a complex pattern of functional redundancy and
regulatory interaction involving all Gli proteins. Trans-
genic mice with homozygous Gli1zfd null mutation that
deletes the exons encoding the DNA-binding zinc finger
domains, reportedly exhibit no phenotype (Park et al.,
2000). Meanwhile, Gli1zfd/zfd; Gli2zfd/ double mutants ex-
hibit a marked phenotype that is more severe when both
Gli2 alleles are mutated (Park et al., 2000). And, recently,
Gli1 was shown to partially rescue function of Gli2 (Bai and
Joyner, 2001). These observations suggest important func-
tional redundancy of Gli1 and Gli2. Gli3 also plays an
important role in hedgehog signaling. While Gli3 is thought
to act primarily as a transcriptional repressor, there is also
evidence that it may be required for Gli1 transcriptional
activity (Dai et al., 1999). In light of these observations, and
the report that Gli1zfd/zfd mice are fertile, we would not
interpret our data as evidence for a role of Gli1 as the
exclusive transcriptional mediator of Shh actions on pros-
tate budding. The colocalization of Gli1 and Gli2 expres-
sion in mesenchyme immediately surrounding epithelial
Shh expression in prostate buds is certainly consistent with
Gli1 and Gli2 possibly sharing transactivating functions to
promote Shh-mediated prostate budding. In this case, the
dual inhibition of Gli1 and Gli2 expression by cyclopamine
could be critical to the observed effect on ductal budding.
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